e-Drug3D

157

CHLOROPROCAINE


INN
CHLOROPROCAINE

cas 133-16-4
CLASS

NERVOUS SYSTEM
ANESTHETIC

ROUTE (list)

INJECTION INTRATHECAL OPHTHALMIC

ATC code

N01BA04
S01HA08

PK parameters

Tmax 0.15 HOUR

Target

TARGET SODIUM CHANNEL

DrugCentral

Sodium channel protein type 10 subunit alpha UNIPROT Q9Y5Y9 SCN10A

Download SDF file 2-diethylaminoethyl 4-amino-2-chlorobenzoate

Formula:
C13H19ClN2O2

Calculated chemical properties:

MW 270.75
NB_atoms 18
XLogP 2.42
PSA 50.487
NB_HD 2
NB_HA 4
fsp3 0.46
Lipinski(0=no;1=yes) 1

FDA
NDA 009435 (pdf not found) INN (CHLOROPROCAINE HYDROCHLORIDE) NESACAINE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 1955
NDA 087446 (pdf not found) INN (CHLOROPROCAINE HYDROCHLORIDE) CHLOROPROCAINE HYDROCHLORIDE (HOSPIRA) APPROVAL= AP YEAR= 1982 DISCONTINUED
NDA 087447 (pdf not found) INN (CHLOROPROCAINE HYDROCHLORIDE) CHLOROPROCAINE HYDROCHLORIDE (HOSPIRA) APPROVAL= AP YEAR= 1982 DISCONTINUED
NDA 040273 (pdf not found) INN (CHLOROPROCAINE HYDROCHLORIDE) CHLOROPROCAINE HYDROCHLORIDE (HIKMA) APPROVAL= AP YEAR= 1998
NDA 208791 (pdf not found) INN (CHLOROPROCAINE HYDROCHLORIDE) CLOROTEKAL (B BRAUN MEDICAL) APPROVAL= AP YEAR= 2017 DISCONTINUED
NDA 216227 (pdf not found) INN (CHLOROPROCAINE HYDROCHLORIDE) IHEEZO (HARROW EYE) APPROVAL= AP YEAR= 2022

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL